Sprint Bioscience AB banner
S

Sprint Bioscience AB
STO:SPRINT

Watchlist Manager
Sprint Bioscience AB
STO:SPRINT
Watchlist
Price: 1.895 SEK -1.3% Market Closed
Market Cap: kr200m

Wall Street
Price Targets

SPRINT Price Targets Summary
Sprint Bioscience AB

Wall Street analysts forecast SPRINT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SPRINT is 3.366 SEK with a low forecast of 3.333 SEK and a high forecast of 3.465 SEK.

Lowest
Price Target
3.333 SEK
76% Upside
Average
Price Target
3.366 SEK
78% Upside
Highest
Price Target
3.465 SEK
83% Upside
Sprint Bioscience AB Competitors:
Price Targets
JACK
Jack in the Box Inc
51% Upside
PWP
Perella Weinberg Partners
43% Upside
NNOX
Nano-X Imaging Ltd
181% Upside
IBEX
Ibex Ltd
41% Upside
0HQ1
Brooks Automation Inc
53% Upside

Revenue
Forecast

43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
43% / Year
Past Growth
-19% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 12 years the compound annual growth rate for Sprint Bioscience AB's revenue is 43%. The projected CAGR for the next 3 years is -19%.

Operating Income
Forecast

N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat
N/A
Past Growth
-73% / Year
Estimated Growth
Estimates Accuracy
15%
Average Beat

The compound annual growth rate of Sprint Bioscience AB's operating income for the next 3 years is -73%.

Net Income
Forecast

N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-69%
Average Miss
N/A
Past Growth
-24% / Year
Estimated Growth
Estimates Accuracy
-69%
Average Miss

The compound annual growth rate of Sprint Bioscience AB's net income for the next 2 years is -24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPRINT's stock price target?
Price Target
3.366 SEK

According to Wall Street analysts, the average 1-year price target for SPRINT is 3.366 SEK with a low forecast of 3.333 SEK and a high forecast of 3.465 SEK.

What is Sprint Bioscience AB's Revenue forecast?
Projected CAGR
-19%

For the last 12 years the compound annual growth rate for Sprint Bioscience AB's revenue is 43%. The projected CAGR for the next 3 years is -19%.

What is Sprint Bioscience AB's Operating Income forecast?
Projected CAGR
-73%

The compound annual growth rate of Sprint Bioscience AB's operating income for the next 3 years is -73%.

What is Sprint Bioscience AB's Net Income forecast?
Projected CAGR
-24%

The compound annual growth rate of Sprint Bioscience AB's net income for the next 2 years is -24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett